Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
0% from low
Borrow rate
2.46%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3.4M | $5.9M | $11.8M | $14.5M | $15.3M |
| Cost of revenue | $0 | $0 | $0 | $3.3M | $6.0M | $10.6M | $13.9M | $15.0M |
| Gross profit | $0 | $0 | $0 | $60.0K | −$96.0K | $1.3M | $647.0K | $276.0K |
| Gross margin | — | — | — | 1.8% | -1.6% | 10.8% | 4.5% | 1.8% |
| R&D | $0 | $0 | $0 | $2.5M | $5.3M | $16.3M | $24.1M | $15.2M |
| Operating income | −$2.7K | −$60 | −$306.0K | −$17.6M | −$35.3M | −$77.4M | −$118.2M | −$103.7M |
| EBITDA | −$2.7K | −$60 | $856.4K | −$17.4M | −$34.8M | −$75.1M | −$113.7M | −$97.9M |
| Net income | −$2.7K | −$60 | $856.4K | −$20.1M | −$36.5M | −$78.3M | −$116.7M | −$100.9M |
| Net margin | — | — | — | -598.4% | -619.8% | -661.7% | -803.7% | -659.6% |
| EPS (diluted) | -0.00 | -0.00 | 0.09 | -2.81 | -2.15 | -2.71 | -3.88 | -3.09 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $25M | $-1.07 | $-1.07–$-1.07 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds DMTKQ.
No tracked institution reports a position in DMTKQ as of their last filing.
No one on the platform has traded DMTKQ yet.
| +0.00% |
| $3915 |
| — |
| GTHRGeneThera, Inc. | $0.00 | +0.00% | $3533 | — |
| GWHPGlobal WholeHealth Partners Corporation | $0.00 | -90.00% | $1313 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.